semaglutide patent expiration semaglutide patent expiry date Ozempic's Protection Starts to Expire in 2026. What Next? Ozempic's Key Molecule To Go

Semaglutide is a singleagonist peptide that selectively activates the glucagon-like peptide-1 receptor (GLP-1R), whereas tirzepatide is a dual agonist that activates both the GLP-1 receptor and the glucose-dependent insulinotropic polypeptide receptor (GIPR)

Centanni M, Duntas L, Feldt-Rasmussen U, Koehrle J, Peeters RP, Razvi S et al (2025) ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism

Clinical trials have not reported any serious reactions or toxicities [42]

Sustained moderate activity like hiking is one of the most effective ways to preserve muscle mass during weight loss, support cardiovascular health, and improve insulin sensitivity, all goals that align directly with what tirzepatide and semaglutide are doing metabolically

That level of risk and monitoring usually matches the 99214 description and deserves to be coded that way